| PERIOD ENDING | 25-Jul-08 | 25-Apr-08 | 25-Jan-08 | 26-Oct-07 | | Total Revenue | 3,706,000 | 3,860,000 | 3,405,000 | 3,123,000 | | Cost of Revenue | 855,000 | 944,000 | 870,000 | 840,000 | | | Gross Profit | 2,851,000 | 2,916,000 | 2,535,000 | 2,283,000 | | | Operating Expenses | | Research Development | 324,000 | 348,000 | 329,000 | 298,000 | | Selling General and Administrative | 1,469,000 | 1,485,000 | 1,455,000 | 1,107,000 | | Non Recurring | 96,000 | 74,000 | 754,000 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 962,000 | 1,009,000 | (3,000) | 878,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (198,000) | 212,000 | 55,000 | | Earnings Before Interest And Taxes | 962,000 | 811,000 | 209,000 | 933,000 | | Interest Expense | 9,000 | (193,000) | 75,000 | 65,000 | | Income Before Tax | 953,000 | 1,004,000 | 134,000 | 868,000 | | Income Tax Expense | 206,000 | 191,000 | 57,000 | 202,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 747,000 | 813,000 | 77,000 | 666,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 747,000 | 813,000 | 77,000 | 666,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $747,000 | $813,000 | $77,000 | $666,000 |
|
2.05% Nasdaq 
Income Statement
